Belviq (generic name: lorcaserin) is a popular prescription weight-loss drug made by Eisai Inc. to help people experiencing obesity and weight-related health issues curb their hunger. Alarmingly, a U.S. Food and Drug Administration (FDA) safety trial concluded that the drug could increase the risk of several different types of cancer, including pancreatic, lung, and colorectal cancer. Those individuals who participated in the clinical trial reported certain types of cancer with some types occurring more frequently in the lorcaserin group, including pancreatic, colorectal, and lung. As a result, the FDA issued a full Belviq recall in February 2020.
?
If you or a loved one took Belviq, Belviq XR, or another brand of lorcaserin, and you were diagnosed with cancer, you may be entitled to file a Belviq lawsuit and receice compensation from the drug’s manufacturer. Fill out a free case review form to find out if you are owed money for damages and talk to a Belviq Lawyer about a Belviq lawsuit.
109 Summit Ridge Ct. Nashville, Tennessee 37215
(855) Tim-MLaw (855-846-6529)
tmiles@timmileslaw.com
https://www.classactionlawyertn.com/belviq-class-action-lawsuit.html
